ライフサイエンスコーパス: pericardial

1 as introduced via a deflectable sheath after pericardial access by subxiphoid puncture.

2 cular arrhythmias is often limited even when pericardial access is successful.

3 PN displacement via percutaneous pericardial access was attempted in 13 patients (age 49+

4 There was no major complication related to pericardial access.

5 nd other associated comorbidities related to pericardial access.

6 rapericardial delivery showed no evidence of pericardial adhesion and/or effusion or adverse effect o

7 ith prohibitive epicardial access because of pericardial adhesions (16), and anatomic barriers to abl

8 without x-ray/MR imaging (n = 3) resulted in pericardial adhesions and poor hMSC viability after 1 we

9 In cardiac surgery, pericardial adhesions are particularly problematic durin

10 In a rat model of severe pericardial adhesions, the hydrogel markedly reduced the

11 olution for the prevention of post-operative pericardial adhesions.

12 vivo for two weeks, reduces the formation of pericardial adhesions.

13 The pericardial adipose tissue (AT) contains a high density

14 Increased pericardial adipose tissue is associated with higher ris

15 tus was independently associated with larger pericardial adipose tissue volume and to explore possibl

16 Larger pericardial adipose tissue volume was associated with lo

17 Pericardial adipose tissue volume was measured using car

18 e, and indinavir were associated with larger pericardial adipose tissue volume.

19 dence interval [CI], 10-23; P < .001) larger pericardial adipose tissue volume.

20 th l6 mL (95% CI, -6 to -25; P = .002) lower pericardial adipose tissue volume.

21 tus was independently associated with larger pericardial adipose tissue volume.

22 ment of fat depots (visceral adipose tissue, pericardial adipose tissue, and periaortic adipose tissu

23 , we investigated IL-10-producing B cells in pericardial adipose tissues (PATs) and their role in the

24 Reduction of pericardial adipose tissues is independently associated

25 rmly distributed on the epicardium following pericardial administration, displaying a half-life of 2.

26 rapulmonary disease (central nervous system, pericardial among other sites) are provided.

27 s in men, especially in gluteus maximus; and pericardial and aortic perivascular fat mainly in women.

28 us ethanol ablation, but 1 patient developed pericardial and pleural effusion attributed to pericardi

29 owed a 4.5-fold increase in the incidence of pericardial and yolk sac edema relative to controls.

30 h normal systolic function undergoing bovine pericardial aortic valve replacement, the prevalence of

31 antify body length, circulation, heart rate, pericardial area (a biomarker for cardiac looping defect

32 ength despite the absence of DPHP effects on pericardial area, suggesting that DPHP-induced cardiac d

33 ll these effects was confirmed by removal of pericardial AT and ex vivo coculture with pericardial AT

34 of pericardial AT and ex vivo coculture with pericardial AT and granulocyte progenitors.

35 esponses after MI, we surgically removed the pericardial AT and performed B-cell depletion and granul

36 findings unveil a new mechanism by which the pericardial AT coordinates immune cell activation, granu

37 The relevance of the pericardial AT in mediating all these effects was confir

38 impaired dendritic cell (DC) trafficking on pericardial AT inflammatory responses was tested in CCR7

39 on fraction in CB2(-/-) mice were limited by pericardial AT removal.

40 hat activated DCs migrate from infarcts into pericardial AT via CCR7.

41 ion inhibited DC and T-cell expansion within pericardial AT, and translated into reduced bone marrow

42 -stimulating factor-producing B cells within pericardial AT, but not spleen or lymph nodes.

43 Leukocytes in murine hearts, pericardial AT, spleen, mediastinal lymph nodes, and bon

44 sociated with higher DC and T-cell counts in pericardial AT, which outnumbered DCs and T cells in lym

45 cient to assess the safety of AVR with other pericardial bioprostheses in children and the youngest a

46 ve replacement (AVR) with current-generation pericardial bioprostheses in young patients is limited.

47 median follow-up, 13.7 months) with a bovine pericardial bioprosthesis at </=30 years of age.

48 atients with difficult pericardiocentesis or pericardial biopsy in a noninvasive manner using on the

49 The diagnostic yield of pericardial biopsy was very low (10.2%).

50 plications (pleuro-pericardial fistula 1 and pericardial bleeding 1).

51 Pericardial bleeding occurred in 4 patients with epicard

52 far the modality of choice for depiction of pericardial calcifications.

53 ) macrophages in the peritoneal, pleural and pericardial cavities.

54 We found that disruption of the pericardial cavity accelerated maladaptive post-MI cardi

55 ion of the caval veins combined with ectopic pericardial cavity formation.

56 l cells (CCs) and the surrounding non-muscle pericardial cells (PCs), development of which is regulat

57 nding protein (RHBP) that transports heme to pericardial cells for detoxification and to growing oocy

58 Infarcted mice also had larger pericardial clusters and 3-fold upregulated numbers of g

59 To study the relevance of pericardial clusters during inflammatory responses after

60 Stabilized, acellular, equine pericardial collagen matrix (sPCM) wound care dressing i

61 usion (2.6%), vascular complications (2.0%), pericardial complications (1.4%), open heart surgery (0.

62 investigated common complications including pericardial complications (hemopericardium, cardiac tamp

63 ing death, stroke, intracerebral hemorrhage, pericardial complications, hematoma or hemorrhage, blood

64 rdiac myocyte, including important roles for pericardial constraint, ventricular interaction, and alt

65 Pericardial contrast injection was observed in 4 apical

66 cele, ectopia cordis, distal sternal defect, pericardial defect, anterior diaphragmatic defect or int

67 We provide evidence that pericardial defects are created by abnormal localization

68 matory therapy, a quantitative assessment of pericardial DHE can provide incremental information to p

69 However, a quantitative assessment of pericardial DHE has not been performed, and the hierarch

70 clinical factors, inflammatory markers, and pericardial DHE is unknown.

71 When quantitative pericardial DHE was added to a model that included age,

72 estergren sedimentation rates, and increased pericardial DHE were all significantly associated with c

73 Pericarditis is the most common form of pericardial disease and a relatively common cause of che

74 Patients who visited the Pericardial Disease Clinic of Samsung Medical Center wit

75 Management of pericardial disease in cancer patients also posed clinic

76 s on the rapidly evolving insights regarding pericardial disease provided by modern imaging modalitie

77 ypertension, primary cardiac involvement, or pericardial disease should be reconsidered and updated.

78 Pericarditis is the most common form of pericardial disease worldwide and may recur in as many a

79 eart disease, heart failure, cardiac masses, pericardial disease, and coronary artery disease.

80 hypertension, QT prolongation, arrhythmias, pericardial disease, and radiation-induced cardiotoxicit

81 stive heart failure, valvular heart disease, pericardial disease, conduction abnormalities, and sudde

82 otoxicosis, acute alcohol consumption, acute pericardial disease, pulmonary embolism, or other acute

83 FDG-PET/CT) in the differential diagnosis of pericardial disease.

84 have a restrictive cardiomyopathy or chronic pericardial disease.

85 colchicine in cardiovascular medicine beyond pericardial disease.

86 nce the diagnostic efficacy in patients with pericardial disease.

87 urpose of the differential diagnosis was not pericardial disease; (2) the patient had a known advance

88 atients suspected of having or known to have pericardial disease; however, cardiac computed tomograph

89 rdiac Failure, Cardiomyopathies/Myocardial & Pericardial Diseases, Cardio-oncology, Congenital Heart

90 rdiac Failure, Cardiomyopathies/Myocardial & Pericardial Diseases, Congenital Heart Disease, Coronary

91 rdiac Failure, Cardiomyopathies/Myocardial & Pericardial Diseases, Congenital Heart Disease, Coronary

92 Pericardial diseases, Takotsubo syndrome, arrhythmias, a

93 A pericardial drain was placed and pericardial fluid was s

94 Her symptoms recurred 3 days later, and a pericardial drain was placed.

95 ics were initialized, and minimally invasive pericardial drainage and esophageal stenting were perfor

96 Diagnosis and management with pericardial drainage and esophageal stenting, as well as

97 ents were randomized to sternotomy and 56 to pericardial drainage and wash-out only.

98 h tamponade decompression syndrome following pericardial drainage.

99 Nanoparticle (NP)-based pericardial drug delivery could provide a strategy to co

100 s displayed cardiac abnormalities, including pericardial edema and heart failure.

101 , with circulatory disruption culminating in pericardial edema and other secondary malformations.

102 P-induced cardiac defects are independent of pericardial edema formation.

103 istent with reduced heart rate and increased pericardial edema in larvae exposed to slick oil but not

104 s a more accurate predictor of lethality and pericardial edema than polycyclic aromatic hydrocarbon (

105 Mortality and pericardial edema was lowest in dilbit WAF-exposed embry

106 Pericardial edema was the most sensitive sublethal effec

107 nts exhibited hypersusceptibility to develop pericardial edema when challenged by crowding stress or

108 Here, we report successful treatment of pericardial edema with propranolol in a patient with Hyp

109 Zebrafish lacking sox9b showed pericardial edema, an elongated heart, and reduced blood

110 oss of the tubule brush border, reduced GFR, pericardial edema, and increased mortality.

111 recapitulated a heart failure phenotype with pericardial edema, decreased ventricular systolic functi

112 ediated knockdown of s1pr1 causes global and pericardial edema, loss of blood circulation, and vascul

113 brafish resulted in renal tubule defects and pericardial edema, phenotypes typically induced by kidne

114 ration barrier function, with development of pericardial edema, suggesting an important role of THSD7

115 ications were device embolization (1.9%) and pericardial effusion (1.9%), with no cases of periproced

116 ronary syndromes (ACS) (1C), the presence of pericardial effusion (1C), cardiac tamponade (1B), valvu

117 sion (12%), reticular infiltration (4%), and pericardial effusion (4%).

118 kg every 4 weeks plus tremelimumab 1 mg/kg), pericardial effusion (durvalumab 20 mg/kg every 4 weeks

119 , 1.777-6.584; P<0.001), and the presence of pericardial effusion (HR, 1.38; 95% confidence interval,

120 pericarditis post-operatively (n = 2), late pericardial effusion (n = 1), unexplained sudden death (

121 dyspnoea (n=3 [5%]), pneumonitis (n=3 [5%]), pericardial effusion (n=2 [3%]), and upper respiratory i

122 onfidence interval, 1.4-6.2; P<0.001), and a pericardial effusion (odds ratio, 2.5; 95% confidence in

123 Pericardial effusion (PE) is common in cancer patients,

124 prior sternotomy, there were no instances of pericardial effusion after extraction.

125 ave confirmative diagnosis using a serology, pericardial effusion analysis or biopsy.

126 cidence of acute severe pericarditis delayed pericardial effusion and gastrointestinal adverse effect

127 t pain and epigastric pain was found to have pericardial effusion and pneumopericardium on computed i

128 of Yap in Llgl1-depleted embryos ameliorated pericardial effusion and restored blood flow velocity.

129 h decompensated congestive heart failure and pericardial effusion diagnosed on echocardiography.

130 cation, 2 for endoleak correction, and 2 for pericardial effusion drainage.

131 tive model: p = 0.0161) were associated with pericardial effusion in females relative to healthy fema

132 A pericardial effusion occurred in 1 patient: pericardioce

133 Significant pericardial effusion occurred in 16 patients (10.4%).

134 disability, be complicated by either a large pericardial effusion or tamponade, and carry a significa

135 spital death, myocardial infarction, stroke, pericardial effusion or tamponade, percutaneous coronary

136 patients; the most common complications were pericardial effusion requiring intervention (1.39%) and

137 rformed safely in the absence of preexisting pericardial effusion to provide a novel route for cardia

138 dure-related complications included a single pericardial effusion treated with percutaneous drainage

139 ity and only 1 hemodynamically insignificant pericardial effusion was observed at follow-up.

140 s with preserved LVEF in 2, and an important pericardial effusion with tamponade in another.

141 ation or PR depression, and new or worsening pericardial effusion).

142 re echocardiography domains (adequate views, pericardial effusion, acute cor pulmonale, left ventricu

143 int: symptomatic cardiac events (symptomatic pericardial effusion, acute coronary syndrome, pericardi

144 mplications were shock, cardiac arrhythmias, pericardial effusion, and coronary artery dilatation.

145 creased aspartate aminotransferase, syncope, pericardial effusion, and hyperkalaemia, and grade 4 inc

146 sia, patent ductus arteriosus, cardiomegaly, pericardial effusion, and lymphoedema.

147 e rates of death, stroke, systemic embolism, pericardial effusion, and major bleeding were 5.8%, 1.9%

148 included appendicitis, spontaneous abortion, pericardial effusion, and seizure; none of the events oc

149 ted in larger and dysmorphic cardiomyocytes, pericardial effusion, impaired blood flow and aberrant v

150 is accompanied by hypotension and cyanosis, pericardial effusion, low voltage on the electrocardiogr

151 f mortality included age, ejection fraction, pericardial effusion, N-terminal pro-B-type natriuretic

152 rdiomyopathy, who also exhibit polycythemia, pericardial effusion, or goiter should be evaluated for

153 Four patients had bleeding complications (pericardial effusion, pericardial hematoma, hemoperitone

154 n, myocardial performance index, presence of pericardial effusion, pulmonary vascular resistance, car

155 g, including mediastinal lymphadenopathy and pericardial effusion, showed no statistically significan

156 Knockdown of emp2 in zebrafish resulted in pericardial effusion, supporting the pathogenic role of

157 ve leaflets, and interatrial septum and mild pericardial effusion.

158 ed satisfactory device position and excluded pericardial effusion.

159 lar right atrial mass and moderate to severe pericardial effusion.

160 rdial rub, electrocardiographic changes, and pericardial effusion.

161 chest were obtained and indicated increasing pericardial effusion.

162 raphic changes and, at times, accompanied by pericardial effusion.

163 olated without steam pop, impedance rise, or pericardial effusion.

164 anized because of hypotension from a serious pericardial effusion.

165 icular dilation and dysfunction, and a large pericardial effusion.

166 raphic scan demonstrated a moderate to large pericardial effusion.

167 b: acute renal failure; pleural effusion and pericardial effusion; and brain metastasis.

168 function, aortic or mitral valve disease, or pericardial effusion; and used transthoracic echocardiog

169 mplications occurred in 5 patients (0.4%): 2 pericardial effusions (1 intraoperative, 1 after 30 days

170 Pericardial effusions and myocardial fibrosis were 3 and

171 Pericardial effusions requiring surgical repair decrease

172 ere was a significantly higher rate of large pericardial effusions with LBN compared with MPN (8.1% v

173 There were no pericardial effusions, but serious procedure/device-rela

174 by the presence of fetal ascites, pleural or pericardial effusions, skin edema, cystic hygroma, incre

175 l myocardial edema and fibrosis and frequent pericardial effusions.

176 sia, pleural effusions, chylothoraces and/or pericardial effusions.

177 II or III, right ventricular dysfunction and pericardial effusions.

178 ally presented with hemothoraces rather than pericardial effusions.

179 ral cavity rapidly activates mediastinal and pericardial FALCs.

180 Hence, pericardial fat accumulation is associated with alterati

181 se in ln-transformed FGF21 levels), but less pericardial fat accumulation over time (0.191 cm(3)/year

182 F21 levels tended to be associated with less pericardial fat accumulation over time.

183 In view of evidence linking pericardial fat accumulation with increased cardiovascul

184 l relationship of baseline FGF21 levels with pericardial fat accumulation.

185 subcutaneous adipose tissue, epicardial and pericardial fat by MRI in 75 nondiabetic men.

186 Progressive pericardial fat expansion and inflammation are associate

187 Myocardial triglyceride, epicardial and pericardial fat increased with increasing amount of live

188 subcutaneous fat index, visceral fat index, pericardial fat index, and liver fat fraction by magneti

189 Increased pericardial fat is associated with worse cardiovascular

190 specific long-term dietary interventions on pericardial fat tissue mobilization are sparse.We sought

191 Pericardial fat TNF-alpha expression was upregulated in

192 e hypothesized that progressive increases in pericardial fat volume and inflammation prospectively da

193 ic Study of Atherosclerosis (MESA) with both pericardial fat volume and plasma FGF21 levels measured

194 ine FGF21 levels were associated with higher pericardial fat volume at baseline (2.381 cm(3) larger i

195 FGF21 levels were positively associated with pericardial fat volume at baseline (beta = 0.055, p < 0.

196 igated the relationship of FGF21 levels with pericardial fat volume in participants free of clinical

197 broblast growth factor 21 (FGF21) levels and pericardial fat volume in post-menopausal women and high

198 Nevertheless, such change in pericardial fat volume is very modest and could be due t

199 4746 participants had pericardial fat volume measured in at least one follow-u

200 When assessing change in pericardial fat volume over a mean duration of 3.0 years

201 at volume at baseline (2.381 cm(3) larger in pericardial fat volume per one SD increase in ln-transfo

202 ls were significantly associated with higher pericardial fat volume, independent of traditional CVD r

203 , myocardial fibrosis, aortic stiffness, and pericardial fat volume.

204 Pericardial fat volumes and LDL (low-density lipoprotein

205 Pericardial fat volumes were evaluated using multidetect

206 ease, kidney disease, systemic inflammation, pericardial fat, and tobacco use.

207 Myocardial triglyceride, epicardial and pericardial fat, VAT, and subcutaneous adipose tissue in

208 tients developed acute complications (pleuro-pericardial fistula 1 and pericardial bleeding 1).

209 = 76), cerebral spinal fluid (CSF; n = 152), pericardial fluid (n = 131), or urine (n = 173) specimen

210 uated the diagnostic accuracy of urinary and pericardial fluid (PF) lipoarabinomannan (LAM) assays in

211 Kprest, 0.01 for the blood flow through the pericardial fluid [L/h], and 0.78 for the P-parameter de

212 The diagnosis is often troublesome because pericardial fluid analysis or biopsy does not always pro

213 The likelihood of survival if pericardial fluid and cardiac motion were both absent wa

214 rameter describing the diffusion between the pericardial fluid and epicardium [L/h].

215 te or inadequate with presence or absence of pericardial fluid and/or cardiac motion.

216 Gata6(+) macrophages in mouse pericardial fluid contributed to the reparative immune r

217 Initial pericardial fluid study results are presented in the Tab

218 118.1 U/L (normal range, 0.0-11.3 U/L) from pericardial fluid was reported from the laboratory.

219 A pericardial drain was placed and pericardial fluid was sent to the laboratory for evaluat

220 r, platelet count <20,000/mul, and malignant pericardial fluid were independently associated with poo

221 epicardium, midmyocardium, endocardium, and pericardial fluid, and accounted for cardiac metabolism

222 Gata6(+) macrophages were present in human pericardial fluid, supporting the notion that this repar

223 , 28.9% demonstrated cardiac motion and 8.6% pericardial fluid.

224 leeding complications (pericardial effusion, pericardial hematoma, hemoperitoneum, and pericardial ta

225 Mycobacterium tuberculosis culture and/or pericardial histology were the reference standard for de

226 catheter with CF sensor was introduced via a pericardial incision onto/in parallel with ventricular e

227 sonance imaging may aid in the assessment of pericardial inflammation and constriction; 3) given phen

228 athway effectors, developed profound post-MI pericardial inflammation and myocardial fibrosis, result

229 ceptable electric parameters without chronic pericardial inflammation in this canine model and offers

230 There was no evidence for late pericardial inflammation or effusion.

231 Pericardial inflammation was quantified on short-axis DH

232 ion (n=1 [2%]), pleural effusion (n=1 [2%]), pericardial infusion (n=1 [2%]), upper gastrointestinal

233 ricardial and pleural effusion attributed to pericardial instrumentation.

234 30 minutes after reperfusion, we performed pericardial irrigation with warm or cold saline for 60 m

235 /-3%; P<0.01) and showed intramyocardial and pericardial late gadolinium enhancement.

236 ricarditis refers to the inflammation of the pericardial layers, resulting from a variety of stimuli

237 a self-expanding, nitinol valve with bovine pericardial leaflets that is placed using a transapical

238 Murine pericardial lymphoid clusters were visualized in mice su

239 s (deep and superficial subcutaneous, liver, pericardial, muscle, pancreas, and renal sinus) by magne

240 IDGF2 accumulation was found at garland and pericardial nephrocytes supporting its role in organisma

241 acent to which are pairs of highly endocytic pericardial nephrocytes that modulate cardiac function b

242 ologs of nephrin and Neph1, respectively, in pericardial nephrocytes.

243 f myocardial penetration and retention after pericardial NP drug delivery.

244 gical defects including hypopigmentation and pericardial oedema.

245 ent mortality with associated development of pericardial oedemas and cardiac damage.

246 y study end points were postoperative AF and pericardial or pleural effusion.

247 neuropeptides in extracts from the brain and pericardial organs than the conventional data dependent

248 oximately 1.5-fold more neuropeptides in the pericardial organs.

249 ronchus was closed by means of an autologous pericardial patch.

250 NP covalently linked to pericardial patches are a novel composite delivery syste

251 NP were covalently linked to pericardial patches using EDC/NHS chemistry and could de

252 8%; 95% CI, -2.2% to 17.6%) or postoperative pericardial/pleural effusion (colchicine, 103 patients [

253 but not of postoperative AF or postoperative pericardial/pleural effusion.

254 mL/kg for airway pressure, pleural pressure, pericardial pressure, and central venous pressure, respe

255 ssure, change in pleural pressure, change in pericardial pressure, and change in central venous press

256 Central venous pressure, airway pressure, pericardial pressure, and pleural pressure; pulse pressu

257 al electroporation ablation after subxiphoid pericardial puncture can create deep, wide, and transmur

258 with various energy levels after subxiphoid pericardial puncture.

259 chest intact in the pig model, percutaneous pericardial resection again blunted the increase in LV e

260 eline and after saline load before and after pericardial resection in normal canines with open (n=3)

261 his proof of concept study demonstrates that pericardial resection through a minimally invasive percu

262 s in obese HFpEF was associated with greater pericardial restraint and heightened ventricular interde

263 ad independent of right heart congestion and pericardial restraint, was similar in TR and controls (6

264 sessment of cardiac structure, function, and pericardial restraint.

265 levated filling pressures through heightened pericardial restraint.

266 on clinical criteria including chest pain, a pericardial rub, electrocardiographic changes, and peric

267 nce of 2 of 4 clinical criteria (chest pain, pericardial rubs, widespread ST-segment elevation or PR

268 not function in isolation, sharing a common pericardial sac and interventricular septum.

269 ating chest trauma by detecting blood in the pericardial sac.

270 the presence of a hemothorax and air in the pericardial sac.

271 d distant endocarditis complications such as pericardial sequelae, myocarditis, and embolic events is

272 a reference region, and then quantifying the pericardial signal that was >6 SD above the reference.

273 f resident cavity macrophages located in the pericardial space adjacent to the site of injury.

274 s demonstrate the potential of utilizing the pericardial space as a sustained drug-eluting reservoir

275 the epicardium with saline infusion into the pericardial space at 39 sites.

276 lly safe and effective, but erosion into the pericardial space or aorta has been described.

277 ever, CABG patients had a lower incidence of pericardial tamponade (0.1% versus 1.0%; P=0.002) and pe

278 The prevalence of pericardial tamponade (1%) was similar at all INRs.

279 occlusive mesenteric ischemia was induced by pericardial tamponade (n = 12), which decreased superior

280 at the vascular access site, hemolysis, and pericardial tamponade occurred in 34 (28.6%), 9 (7.5%),

281 A higher rate of pericardial tamponade was observed in group A (5.2% vers

282 n, pericardial hematoma, hemoperitoneum, and pericardial tamponade).

283 Beyond 1 procedure-related pericardial tamponade, there were no additional primary

284 Procedural complication rates included 39 pericardial tamponades (1.02%) (24 treated percutaneousl

285 or healthy controls; to assess the impact of pericardial thickening detected by cardiac magnetic reso

286 as a significant inverse correlation between pericardial thickness and respective ventricular strains

287 obal longitudinal strain to septal shift and pericardial thickness resulted in improved continuous ne

288 over an immune cardioprotective role for the pericardial tissue compartment and argue for the reevalu

289 elf-expanding nitinol valve made from bovine pericardial tissue that is 14-F compatible with a motori

290 bserved with CD3 biomarker in native porcine pericardial tissue throughout the study.

291 AVR or TAVR with a balloon-expandable bovine pericardial tissue valve by either a transfemoral or tra

292 ither SAVR or TAVR with a balloon expandable pericardial tissue valve.

293 ion (74%), fibrosing mediastinitis (1%), and pericardial tuberculosis (2%).

294 g patients undergoing AVR with Mitroflow LXA pericardial valves are at high risk for rapid progressio

295 derwent aortic valve replacement with bovine pericardial valves from 2004 to 2009 and had normal preo

296 ar calcification); (2) adiposity (defined by pericardial, visceral, hepatic, and intrathoracic fat);

297 ool, leading to failure to expand the dorsal pericardial wall and altered positioning of the cardiac

298 genitors comprising the proepicardium on the pericardial wall, and prevented the formation and migrat

299 th a hemopericardium confirmed at subxiphoid pericardial window (SPW), and no active bleeding, were r

300 y, and had an US scan followed by subxiphoid pericardial window exploration.